Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 4:56:50 PM CDT

Learn about Newser Points »

« Back to the grid | Next story »

FDA Mandates Suicide Risk Assessment in Drug Trials

Posted Jan 24, 08 11:42 AM CST in Science & Health 

(Newser) – The Food and Drug Administration is now requiring drug companies to monitor suicide warning signs in clinical trials for experimental drugs, the New York Times reports. In the wake of studies showing that antidepressants might increase the risk of self-harm in children and teens, the agency is showing an awareness that a surprising variety of drugs can have psychiatric effects.

Clinical trials that must add a suicide assessment to their studies include those for drugs combating epilepsy, incontinence, obesity, and smoking, in addition to depression. Most of these drugs were not previously thought to affect the brain. "Various groups within FDA are now looking at suicidality more broadly as a possible adverse event,” explains one expert.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
Young adults face an increased risk of suicidal thoughts and behavior when they first begin taking antidepressants and should be warned about the danger, federal health officials said Wednesday, May 2,...   (Associated Press)
In this undated photo released by German drug maker Merck & Co., an employee controls samples in the molecular biology department. The FDA has begun requiring more detailed studies of the effects of certain...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 2)

Tags

FDA  • suicide  • antidepressant  • Merck  • clinical trials  • Eli Lilly  • experimental drugs  • anti obesity drugs  • Sanofi Aventis


Loading...

Loading...

Today's Most Popular


Other Science & Health Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »